AG˹ٷ

STOCK TITAN

[8-K] Flora Growth Corp. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Morgan Stanley Finance LLC, guaranteed by Morgan Stanley (NYSE: MS), is marketing “Worst-of RTY & SPX Callable Jump Notes� maturing 5 Aug 2030. The notes are linked to the Russell 2000 (RTY) and the S&P 500 (SPX) and offer 100 % participation in any positive performance of the worst-performing index, subject to the issuer’s right to call.

Early-redemption mechanism: starting 5 Aug 2026 and monthly thereafter (48 dates), the issuer will call the notes if a proprietary risk-neutral model indicates it is economic to do so. Investors receive a fixed “jump� payment that begins at $1,120 (12 % over par) and rises by $10 every month to $1,590 (59 % over par) by July 2030.

At maturity (if never called) investors receive: � par plus 100 % upside on the worst performer, capped only by the 59 % maximum shown in the hypothetical table; � full principal protection—even if either index falls 100 %, payment is still $1,000. The notes pay no periodic coupons.

Key economics: issue price $1,000; estimated value $961.40 (approximately 3.9 % below par, reflecting structuring and hedging costs). CUSIP 61778NDQ1. The securities will not be exchange-listed; liquidity will depend on Morgan Stanley’s secondary market.

Principal risks detailed in the FWP include: call risk (upside cut off), no interest income, credit risk of Morgan Stanley, small-cap exposure via RTY, and potential adverse pricing in secondary trading. Investors should consult the full preliminary pricing supplement and tax discussion before investing.

Morgan Stanley Finance LLC, garantita da Morgan Stanley (NYSE: MS), sta promuovendo le "Worst-of RTY & SPX Callable Jump Notes" con scadenza il 5 agosto 2030. Le note sono collegate al Russell 2000 (RTY) e al S&P 500 (SPX) e offrono una partecipazione del 100% in qualsiasi performance positiva dell'indice con la peggiore performance, soggetta al diritto dell'emittente di richiamare le note.

Meccanismo di rimborso anticipato: a partire dal 5 agosto 2026 e mensilmente in seguito (48 date), l'emittente potrà richiamare le note se un modello proprietario risk-neutral indica che è conveniente farlo. Gli investitori riceveranno un pagamento fisso "jump" che parte da $1.120 (12% sopra il valore nominale) e aumenta di $10 ogni mese fino a $1.590 (59% sopra il valore nominale) entro luglio 2030.

Alla scadenza (se non richiamate) gli investitori riceveranno: � il valore nominale più il 100% dell'apprezzamento sul peggior indice, limitato solo al massimo del 59% indicato nella tabella ipotetica; � protezione completa del capitale—anche se uno degli indici dovesse cadere del 100%, il pagamento sarà comunque di $1.000. Le note non prevedono cedole periodiche.

Elementi economici chiave: prezzo di emissione $1.000; valore stimato $961,40 (circa il 3,9% sotto il valore nominale, riflettendo costi di strutturazione e copertura). CUSIP 61778NDQ1. I titoli non saranno quotati in borsa; la liquidità dipenderà dal mercato secondario di Morgan Stanley.

Principali rischi dettagliati nel FWP includono: rischio di richiamo (limitazione del guadagno), assenza di reddito da interessi, rischio di credito di Morgan Stanley, esposizione a small cap tramite RTY e possibile pricing sfavorevole nel mercato secondario. Gli investitori dovrebbero consultare il supplemento preliminare completo e la discussione fiscale prima di investire.

Morgan Stanley Finance LLC, garantizada por Morgan Stanley (NYSE: MS), está promocionando las "Worst-of RTY & SPX Callable Jump Notes" con vencimiento el 5 de agosto de 2030. Las notas están vinculadas al Russell 2000 (RTY) y al S&P 500 (SPX) y ofrecen una participación del 100% en cualquier rendimiento positivo del índice con peor desempeño, sujeto al derecho del emisor a llamar las notas.

Mecanismo de redención anticipada: a partir del 5 de agosto de 2026 y mensualmente después (48 fechas), el emisor podrá llamar las notas si un modelo propietario neutral al riesgo indica que es económicamente conveniente hacerlo. Los inversores reciben un pago fijo de "salto" que comienza en $1,120 (12% sobre el valor nominal) y aumenta $10 cada mes hasta $1,590 (59% sobre el valor nominal) para julio de 2030.

Al vencimiento (si nunca se llaman) los inversores reciben: � el valor nominal más el 100% de la subida del peor índice, limitado solo por el máximo del 59% mostrado en la tabla hipotética; � protección total del capital—incluso si cualquiera de los índices cae un 100%, el pago sigue siendo $1,000. Las notas no pagan cupones periódicos.

Aspectos económicos clave: precio de emisión $1,000; valor estimado $961.40 (aproximadamente 3.9% por debajo del valor nominal, reflejando costos de estructuración y cobertura). CUSIP 61778NDQ1. Los valores no estarán listados en bolsa; la liquidez dependerá del mercado secundario de Morgan Stanley.

Riesgos principales detallados en el FWP incluyen: riesgo de llamada (limitación de ganancias), sin ingresos por intereses, riesgo crediticio de Morgan Stanley, exposición a small caps vía RTY y posible valoración adversa en la negociación secundaria. Los inversores deben consultar el suplemento preliminar completo y la discusión fiscal antes de invertir.

Morgan Stanley Finance LLC� Morgan Stanley(NYSE: MS)� 보증� 받아 2030� 8� 5� 만기� “Worst-of RTY & SPX Callable Jump Notes”를 마케팅하� 있습니다. � 노트� Russell 2000(RTY)S&P 500(SPX)� 연계되어 있으�, 최악� 성과� � 지수의 긍정� 성과� 대� 100% 참여� 제공합니�. �, 발행자의 � 권리가 적용됩니�.

조기 상환 메커니즘: 2026� 8� 5일부� 매월(� 48�) 발행자가 자체 위험 중립 모델� 따라 경제적이� 판단하면 노트� 콜할 � 있습니다. 투자자는 $1,120(액면가 대� 12%)에서 시작� 매월 $10� 증가하여 2030� 7월에� $1,590(액면가 대� 59%)� 이르� 고정 '점프' 지급금� 받습니다.

만기 �(콜되지 않은 경우) 투자자는 다음� 받습니다: � 액면가와 최악� 지� 상승� 100% (가상의 표에 표시� 59% 최대 한도 적용); � 원금 전액 보호—두 지� � 어느 하나가 100% 하락해도 지급금은 $1,000입니�. 노트� 정기 쿠폰� 지급하지 않습니다.

주요 경제 조건: 발행가 $1,000; 추정 가� $961.40(� 3.9% 액면가 이하, 구조� � 헤지 비용 반영). CUSIP 61778NDQ1. 증권은 거래� 상장되지 않으�, 유동성은 Morgan Stanley� 2� 시장� 따라 달라집니�.

주요 위험은 FWP� 상세� 설명되어 있으�, � 위험(상승 제한), 이자 수익 없음, Morgan Stanley 신용 위험, RTY� 통한 소형� 노출, 2� 시장에서� 불리� 가� 형성 가능성� 포함합니�. 투자자는 투자 � 전체 예비 가� 보충서와 세금 관� 논의� 반드� 검토해� 합니�.

Morgan Stanley Finance LLC, garantie par Morgan Stanley (NYSE : MS), commercialise des "Worst-of RTY & SPX Callable Jump Notes" arrivant à échéance le 5 août 2030. Ces notes sont liées au Russell 2000 (RTY) et au S&P 500 (SPX) et offrent une participation de 100 % à toute performance positive de l'indice le moins performant, sous réserve du droit de rappel de l'émetteur.

Mécanisme de remboursement anticipé : à partir du 5 août 2026 et chaque mois ensuite (48 dates), l'émetteur rappellera les notes si un modèle propriétaire neutre au risque indique que cela est économiquement avantageux. Les investisseurs reçoivent un paiement fixe « jump » commençant à 1 120 $ (12 % au-dessus de la valeur nominale) et augmentant de 10 $ chaque mois pour atteindre 1 590 $ (59 % au-dessus de la valeur nominale) en juillet 2030.

À l'échéance (si jamais rappelées), les investisseurs reçoivent : � le pair plus 100 % de la performance de l'indice le moins performant, plafonné uniquement par le maximum de 59 % indiqué dans le tableau hypothétique ; � protection intégrale du capital—même si l'un des indices chute de 100 %, le paiement reste de 1 000 $. Les notes ne versent aucun coupon périodique.

Principaux éléments économiques : prix d'émission 1 000 $ ; valeur estimée 961,40 $ (environ 3,9 % sous le pair, reflétant les coûts de structuration et de couverture). CUSIP 61778NDQ1. Ces titres ne seront pas cotés en bourse ; la liquidité dépendra du marché secondaire de Morgan Stanley.

Principaux risques détaillés dans le FWP comprennent : risque de rappel (limitation du potentiel de hausse), absence de revenus d'intérêts, risque de crédit de Morgan Stanley, exposition aux small caps via RTY, et risque de prix défavorable sur le marché secondaire. Les investisseurs doivent consulter le supplément de tarification préliminaire complet et la discussion fiscale avant d'investir.

Morgan Stanley Finance LLC, garantiert von Morgan Stanley (NYSE: MS), vermarktet die "Worst-of RTY & SPX Callable Jump Notes" mit Fälligkeit am 5. August 2030. Die Notes sind an den Russell 2000 (RTY) und den S&P 500 (SPX) gekoppelt und bieten 100 % Beteiligung an der positiven Entwicklung des schlechter abschneidenden Index, vorbehaltlich des Rückrufrechts des Emittenten.

Frühzeitiges Rückzahlungsmechanismus: ab dem 5. August 2026 und monatlich danach (insgesamt 48 Termine) wird der Emittent die Notes zurückrufen, wenn ein proprietäres risikoneutrales Modell dies als wirtschaftlich sinnvoll erachtet. Investoren erhalten eine feste "Jump"-Zahlung, die bei $1.120 (12 % über dem Nennwert) beginnt und jeden Monat um $10 bis auf $1.590 (59 % über dem Nennwert) im Juli 2030 ansteigt.

Bei Fälligkeit (sofern nicht zurückgerufen) erhalten Investoren: � Nennwert plus 100 % Aufschlag auf den schlechteren Index, begrenzt durch das maximale 59 % in der hypothetischen Tabelle; � volle Kapitalgarantie—selbst wenn einer der Indizes um 100 % fällt, beträgt die Auszahlung weiterhin 1.000 $. Die Notes zahlen keine periodischen Kupons.

Wesentliche wirtschaftliche Eckdaten: Ausgabepreis 1.000 $; geschätzter Wert 961,40 $ (etwa 3,9 % unter dem Nennwert, reflektiert Strukturierungs- und Absicherungskosten). CUSIP 61778NDQ1. Die Wertpapiere werden nicht an der Börse gehandelt; die Liquidität hängt vom Sekundärmarkt von Morgan Stanley ab.

Hauptrisiken, die im FWP aufgeführt sind, umfassen: Rückrufrisiko (Begrenzung des Aufwärtspotenzials), keine Zinseinnahmen, Kreditrisiko von Morgan Stanley, Small-Cap-Exponierung über RTY und mögliche ungünstige Preisgestaltung im Sekundärhandel. Anleger sollten das vollständige vorläufige Preiszusatzblatt und die steuerlichen Hinweise vor einer Investition sorgfältig prüfen.

Positive
  • Full principal protection at maturity even if RTY or SPX decline 100 %.
  • Early-redemption schedule offers 12 %�59 % fixed upside over five years, providing defined return targets.
  • Exposure to two major equity indices with 100 % participation in worst-performer gains.
Negative
  • No periodic interest; capital is locked without income.
  • Issuer can call at its discretion, capping upside when performance is favourable.
  • Estimated value is $961.40, reflecting ~3.9 % structuring cost borne by investors.
  • Notes are unlisted; secondary liquidity relies solely on Morgan Stanley.
  • Returns may underperform direct equity investment due to call risk and fee drag.
  • Subject to Morgan Stanley credit risk; deterioration could lower secondary prices.

Insights

TL;DR Callable note offers 12�59 % fixed upside or par, but no coupons and significant call, liquidity and credit risks.

The product provides contingent equity exposure with full principal protection—rare among worst-of structures—yet the issuer call option skews returns in Morgan Stanley’s favour. Internal valuation shows a $38.60 discount to issue price, signalling hefty embedded fees. Investors trade away income and open-ended upside for the chance of a 12�59 % lump-sum, which can be truncated at the issuer’s discretion. Given MS’s solid credit profile, default risk is currently low, but spread widening would hurt secondary prices. Overall market impact on MS is immaterial; suitability is limited to investors seeking capital-protected structured notes and comfortable with call risk and illiquidity.

TL;DR Capital-protected, equity-linked notes with rising call payouts; return asymmetry favours issuer, not long-term investors.

If indices rally early, Morgan Stanley will almost certainly call, leaving holders with modest gains versus direct equity exposure. If indices languish, investors tie up capital for up to five years with zero yield. Purchasing below par in secondary markets could improve risk-reward, but primary buyers effectively prepay structuring costs. With prevailing risk-free rates near 3.5 %, the note’s 12 % first-call premium equates to roughly 2.9 % annualised—barely beating Treasuries once credit and liquidity risks are priced. I classify the note as a niche allocation tool rather than a core holding.

Morgan Stanley Finance LLC, garantita da Morgan Stanley (NYSE: MS), sta promuovendo le "Worst-of RTY & SPX Callable Jump Notes" con scadenza il 5 agosto 2030. Le note sono collegate al Russell 2000 (RTY) e al S&P 500 (SPX) e offrono una partecipazione del 100% in qualsiasi performance positiva dell'indice con la peggiore performance, soggetta al diritto dell'emittente di richiamare le note.

Meccanismo di rimborso anticipato: a partire dal 5 agosto 2026 e mensilmente in seguito (48 date), l'emittente potrà richiamare le note se un modello proprietario risk-neutral indica che è conveniente farlo. Gli investitori riceveranno un pagamento fisso "jump" che parte da $1.120 (12% sopra il valore nominale) e aumenta di $10 ogni mese fino a $1.590 (59% sopra il valore nominale) entro luglio 2030.

Alla scadenza (se non richiamate) gli investitori riceveranno: � il valore nominale più il 100% dell'apprezzamento sul peggior indice, limitato solo al massimo del 59% indicato nella tabella ipotetica; � protezione completa del capitale—anche se uno degli indici dovesse cadere del 100%, il pagamento sarà comunque di $1.000. Le note non prevedono cedole periodiche.

Elementi economici chiave: prezzo di emissione $1.000; valore stimato $961,40 (circa il 3,9% sotto il valore nominale, riflettendo costi di strutturazione e copertura). CUSIP 61778NDQ1. I titoli non saranno quotati in borsa; la liquidità dipenderà dal mercato secondario di Morgan Stanley.

Principali rischi dettagliati nel FWP includono: rischio di richiamo (limitazione del guadagno), assenza di reddito da interessi, rischio di credito di Morgan Stanley, esposizione a small cap tramite RTY e possibile pricing sfavorevole nel mercato secondario. Gli investitori dovrebbero consultare il supplemento preliminare completo e la discussione fiscale prima di investire.

Morgan Stanley Finance LLC, garantizada por Morgan Stanley (NYSE: MS), está promocionando las "Worst-of RTY & SPX Callable Jump Notes" con vencimiento el 5 de agosto de 2030. Las notas están vinculadas al Russell 2000 (RTY) y al S&P 500 (SPX) y ofrecen una participación del 100% en cualquier rendimiento positivo del índice con peor desempeño, sujeto al derecho del emisor a llamar las notas.

Mecanismo de redención anticipada: a partir del 5 de agosto de 2026 y mensualmente después (48 fechas), el emisor podrá llamar las notas si un modelo propietario neutral al riesgo indica que es económicamente conveniente hacerlo. Los inversores reciben un pago fijo de "salto" que comienza en $1,120 (12% sobre el valor nominal) y aumenta $10 cada mes hasta $1,590 (59% sobre el valor nominal) para julio de 2030.

Al vencimiento (si nunca se llaman) los inversores reciben: � el valor nominal más el 100% de la subida del peor índice, limitado solo por el máximo del 59% mostrado en la tabla hipotética; � protección total del capital—incluso si cualquiera de los índices cae un 100%, el pago sigue siendo $1,000. Las notas no pagan cupones periódicos.

Aspectos económicos clave: precio de emisión $1,000; valor estimado $961.40 (aproximadamente 3.9% por debajo del valor nominal, reflejando costos de estructuración y cobertura). CUSIP 61778NDQ1. Los valores no estarán listados en bolsa; la liquidez dependerá del mercado secundario de Morgan Stanley.

Riesgos principales detallados en el FWP incluyen: riesgo de llamada (limitación de ganancias), sin ingresos por intereses, riesgo crediticio de Morgan Stanley, exposición a small caps vía RTY y posible valoración adversa en la negociación secundaria. Los inversores deben consultar el suplemento preliminar completo y la discusión fiscal antes de invertir.

Morgan Stanley Finance LLC� Morgan Stanley(NYSE: MS)� 보증� 받아 2030� 8� 5� 만기� “Worst-of RTY & SPX Callable Jump Notes”를 마케팅하� 있습니다. � 노트� Russell 2000(RTY)S&P 500(SPX)� 연계되어 있으�, 최악� 성과� � 지수의 긍정� 성과� 대� 100% 참여� 제공합니�. �, 발행자의 � 권리가 적용됩니�.

조기 상환 메커니즘: 2026� 8� 5일부� 매월(� 48�) 발행자가 자체 위험 중립 모델� 따라 경제적이� 판단하면 노트� 콜할 � 있습니다. 투자자는 $1,120(액면가 대� 12%)에서 시작� 매월 $10� 증가하여 2030� 7월에� $1,590(액면가 대� 59%)� 이르� 고정 '점프' 지급금� 받습니다.

만기 �(콜되지 않은 경우) 투자자는 다음� 받습니다: � 액면가와 최악� 지� 상승� 100% (가상의 표에 표시� 59% 최대 한도 적용); � 원금 전액 보호—두 지� � 어느 하나가 100% 하락해도 지급금은 $1,000입니�. 노트� 정기 쿠폰� 지급하지 않습니다.

주요 경제 조건: 발행가 $1,000; 추정 가� $961.40(� 3.9% 액면가 이하, 구조� � 헤지 비용 반영). CUSIP 61778NDQ1. 증권은 거래� 상장되지 않으�, 유동성은 Morgan Stanley� 2� 시장� 따라 달라집니�.

주요 위험은 FWP� 상세� 설명되어 있으�, � 위험(상승 제한), 이자 수익 없음, Morgan Stanley 신용 위험, RTY� 통한 소형� 노출, 2� 시장에서� 불리� 가� 형성 가능성� 포함합니�. 투자자는 투자 � 전체 예비 가� 보충서와 세금 관� 논의� 반드� 검토해� 합니�.

Morgan Stanley Finance LLC, garantie par Morgan Stanley (NYSE : MS), commercialise des "Worst-of RTY & SPX Callable Jump Notes" arrivant à échéance le 5 août 2030. Ces notes sont liées au Russell 2000 (RTY) et au S&P 500 (SPX) et offrent une participation de 100 % à toute performance positive de l'indice le moins performant, sous réserve du droit de rappel de l'émetteur.

Mécanisme de remboursement anticipé : à partir du 5 août 2026 et chaque mois ensuite (48 dates), l'émetteur rappellera les notes si un modèle propriétaire neutre au risque indique que cela est économiquement avantageux. Les investisseurs reçoivent un paiement fixe « jump » commençant à 1 120 $ (12 % au-dessus de la valeur nominale) et augmentant de 10 $ chaque mois pour atteindre 1 590 $ (59 % au-dessus de la valeur nominale) en juillet 2030.

À l'échéance (si jamais rappelées), les investisseurs reçoivent : � le pair plus 100 % de la performance de l'indice le moins performant, plafonné uniquement par le maximum de 59 % indiqué dans le tableau hypothétique ; � protection intégrale du capital—même si l'un des indices chute de 100 %, le paiement reste de 1 000 $. Les notes ne versent aucun coupon périodique.

Principaux éléments économiques : prix d'émission 1 000 $ ; valeur estimée 961,40 $ (environ 3,9 % sous le pair, reflétant les coûts de structuration et de couverture). CUSIP 61778NDQ1. Ces titres ne seront pas cotés en bourse ; la liquidité dépendra du marché secondaire de Morgan Stanley.

Principaux risques détaillés dans le FWP comprennent : risque de rappel (limitation du potentiel de hausse), absence de revenus d'intérêts, risque de crédit de Morgan Stanley, exposition aux small caps via RTY, et risque de prix défavorable sur le marché secondaire. Les investisseurs doivent consulter le supplément de tarification préliminaire complet et la discussion fiscale avant d'investir.

Morgan Stanley Finance LLC, garantiert von Morgan Stanley (NYSE: MS), vermarktet die "Worst-of RTY & SPX Callable Jump Notes" mit Fälligkeit am 5. August 2030. Die Notes sind an den Russell 2000 (RTY) und den S&P 500 (SPX) gekoppelt und bieten 100 % Beteiligung an der positiven Entwicklung des schlechter abschneidenden Index, vorbehaltlich des Rückrufrechts des Emittenten.

Frühzeitiges Rückzahlungsmechanismus: ab dem 5. August 2026 und monatlich danach (insgesamt 48 Termine) wird der Emittent die Notes zurückrufen, wenn ein proprietäres risikoneutrales Modell dies als wirtschaftlich sinnvoll erachtet. Investoren erhalten eine feste "Jump"-Zahlung, die bei $1.120 (12 % über dem Nennwert) beginnt und jeden Monat um $10 bis auf $1.590 (59 % über dem Nennwert) im Juli 2030 ansteigt.

Bei Fälligkeit (sofern nicht zurückgerufen) erhalten Investoren: � Nennwert plus 100 % Aufschlag auf den schlechteren Index, begrenzt durch das maximale 59 % in der hypothetischen Tabelle; � volle Kapitalgarantie—selbst wenn einer der Indizes um 100 % fällt, beträgt die Auszahlung weiterhin 1.000 $. Die Notes zahlen keine periodischen Kupons.

Wesentliche wirtschaftliche Eckdaten: Ausgabepreis 1.000 $; geschätzter Wert 961,40 $ (etwa 3,9 % unter dem Nennwert, reflektiert Strukturierungs- und Absicherungskosten). CUSIP 61778NDQ1. Die Wertpapiere werden nicht an der Börse gehandelt; die Liquidität hängt vom Sekundärmarkt von Morgan Stanley ab.

Hauptrisiken, die im FWP aufgeführt sind, umfassen: Rückrufrisiko (Begrenzung des Aufwärtspotenzials), keine Zinseinnahmen, Kreditrisiko von Morgan Stanley, Small-Cap-Exponierung über RTY und mögliche ungünstige Preisgestaltung im Sekundärhandel. Anleger sollten das vollständige vorläufige Preiszusatzblatt und die steuerlichen Hinweise vor einer Investition sorgfältig prüfen.


false 2025-06-30 0001790169 00-0000000 Flora Growth Corp. 0001790169 2025-06-30 2025-06-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 30, 2025

FLORA GROWTH CORP.
(Exact name of registrant as specified in its charter)

Ontario 001-40397 Not Applicable
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

3230 W. Commercial Boulevard, Suite 180
Fort Lauderdale, Florida, United States 33132
(Address of principal executive offices) (ZIP Code)

Registrant’s telephone number, including area code: (954) 842-4989

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbols   Name of each exchange on which registered
Common Shares, no par value   FLGC   NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Flora Growth Corp., a corporation organized under the laws of the Province of Ontario (the "Company") held its 2025 Annual and Special Meeting of Shareholders (the "Annual Meeting") on June 30, 2025.

The 2022 Plan Amendment

At the Annual Meeting, the Company's shareholders approved an amendment (the "Amendment") of the Company's 2022 Incentive Compensation Plan (the "2022 Plan") to increase the number of common shares of the Company (the "Common Shares") reserved for issuance to participants under the 2022 Plan from 2,500,000 Common Shares to 4,500,000 Common Shares. Previously, on April 11, 2025, the board of directors of the Company (the "Board") authorized the Amendment, subject to the Company's shareholders approving such Amendment at the Annual Meeting.

The Amendment became effective immediately upon shareholder approval at the Annual Meeting. A more complete summary of the terms of the Amendment is set forth in "Proposal 3: Approval of Amendment to the 2022 Plan" in the Company's definitive proxy statement filed with the Securities and Exchange Commission on May 6, 2025 (the "Proxy Statement"), which description and text are incorporated herein by reference.

The foregoing description of the terms of the Amendment and the description thereof incorporated by reference from the Proxy Statement do not purport to be complete and are qualified in their entirety by reference to the full text of the 2022 Plan, a copy of which is filed as Exhibit 4.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Repricing and Amendment of Vesting Terms of Certain Outstanding Stock Appreciation Rights 

At the Annual Meeting, the Company's shareholders approved the repricing and amendment of vesting terms of certain outstanding Stock Appreciation Rights granted to certain employees and executive officers of the Company (the "Stock Appreciation Rights Repricing"). The Stock Appreciation Rights Repricing became effective immediately upon the closing of the Annual Meeting.

The December 2023 SARs, August 2024 SARs and December 2024 SARs (in each case, as defined in the Proxy Statement) were repriced to an exercise price per right of $0.58, which is equal to the closing price of the Company's Common Shares on Nasdaq on June 30, 2025, the date the Company's shareholders approved the Stock Appreciation Rights Repricing.

The vesting terms of the December 2023 Starke SARs (as defined in the Proxy Statement), of which there are 1,028,665 outstanding, and the August 2024 Starke SARs (as defined in the Proxy Statement), of which there are 575,319 outstanding, were amended such that the first of nine tranches will vest upon the Company's share price increasing by 25% from $0.58, with each tranche thereafter requiring an additional 25% increase in share price to vest in accordance with the following schedule:

Tranche

Percentage Increase in Flora
Growth Corp. Share Price From
Grant Date For Tranche to Vest

1

25%

2

50%

3

75%

4

100%

5

125%

6

150%

7

175%

8

200%

9

225%



The vesting terms of the December 2023 Vaiman SARs (as defined in the Proxy Statement), of which there are 342,888 outstanding, and the August 2024 Vaiman SARs (as defined in the Proxy Statement), of which there are 191,773 outstanding, were amended such that the first of eight tranches will vest upon the Company's share price increasing by 25% from $0.58, with each tranche thereafter requiring an additional 25% increase in share price to vest in accordance with the following schedule:

Tranche

Percentage Increase in Flora
Growth Corp. Share Price From
Grant Date For Tranche to Vest

1

25%

2

50%

3

75%

4

100%

5

125%

6

150%

7

175%

8

200%

The foregoing description of the terms of the Stock Appreciation Rights Repricing and the description thereof incorporated by reference from the Proxy Statement do not purport to be complete and are qualified in their entirety by reference to the full text of the Form of Unvested Stock Appreciation Rights Agreement with respect to the December 2023 SARs and August 2024 SARs (each as defined in the Proxy Statement) and the full text of the Form of Vested Stock Appreciation Rights Agreement with respect to the December 2024 SARs (as defined in the Proxy Statement), copies of which are filed as Exhibit 10.1 and Exhibit 10.2 to this Current Report on Form 8-K, respectively, and are incorporated herein by reference.

Item 5.07 Submission of Matters to a Vote of Security Holders.

The final voting results for the proposals submitted to a vote of the Company's shareholders at the Annual Meeting are as follows:

Proposal 1: Election of five directors to the Board to hold office until the Company's 2026 Annual Meeting of Shareholders or until their respective successors are elected or appointed:

                Broker
Director   For   Against   Abstentions   Non-Votes
Clifford Starke   7,329,521   1,500,756   20,277   4,127,339
Sammy Dorf   8,014,311   815,247   20,996   4,127,339
Edward Woo   8,622,354   204,155   24,045   4,127,339
Manfred Leventhal   8,715,612   114,001   20,941   4,127,339
Harold Wolkin   8,560,356   264,945   25,253   4,127,339

Proposal 2: Reappointment of Davidson & Company LLP, an independent registered public accounting firm, as auditors of the Company for the fiscal year ending December 31, 2025 and authorization of the Board to fix their renumeration.

For   Against   Abstentions
12,637,347   225,303   115,243


 Proposal 3: Approval of an amendment to the Company's 2022 Plan to increase the number of shares issuable thereunder from 2,500,000 to 4,500,000 shares. 

            Broker
For   Against   Abstentions   Non-Votes
5,548,268   3,293,584   8,702   4,127,339

Proposal 4: Approval of the grant of Stock Appreciation Rights to the Company's Chief Executive Officer, Chief Financial Officer, and Executive Chairman. 

            Broker
For   Against   Abstentions   Non-Votes
1,291,659   7,547,118   11,777   4,127,339

Proposal 5: Give our Board the authority, at its discretion, to effect a share consolidation of the Company's outstanding Common Shares at a ratio not less than 10:1 and not greater than 100:1 without reducing the authorized number of Common Shares, and to be effected, if at all, in the sole discretion of our Board at any time within one year of the date of the Annual Meeting without further approval or authorization of our shareholders. 

         
For   Against   Abstentions
10,996,887   1,296,154   684,851

Proposal 6: Approval of the repricing and amendment of vesting terms of certain outstanding Stock Appreciation Rights granted to certain employees and executive officers of the Company. 

            Broker
For   Against   Abstentions   Non-Votes
5,292,718   3,547,911   9,925   4,127,339

Based on the foregoing votes, each of Clifford Starke, Sammy Dorf, Edward Woo, Manfred Leventhal and Harold Wolkin were elected to the Company's Board, and Proposals 2, 3, 5 and 6 were approved. Proposal 4 was not approved. No other proposals were submitted for shareholder approval at the Annual Meeting. 

Item 9.01 Financial Statements and Exhibits.

Exhibit No. Description
4.1 2022 Incentive Compensation Plan
10.1 Form of Unvested Stock Appreciation Rights Agreement, dated June 30, 2025
10.2 Form of Vested Stock Appreciation Rights Agreement, dated June 30, 2025
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  FLORA GROWTH CORP.
     
Date: June 30, 2025 By: /s/ Clifford Starke
  Name: Clifford Starke
  Title: Chief Executive Officer


FAQ

What is the maximum potential return on Morgan Stanley’s Worst-of RTY & SPX Callable Jump Notes?

If never called, the maximum fixed payout is $1,590 per $1,000 note (59 %) on 5 Aug 2030.

When can Morgan Stanley redeem the notes early?

Starting 5 Aug 2026 and monthly thereafter, the issuer may redeem if its valuation model deems it economic, paying the scheduled jump amount.

Do the notes provide any downside protection?

Yes. Holders receive no less than the $1,000 principal at maturity, even if RTY or SPX fall 100 %.

Why is the estimated value ($961.40) below the $1,000 issue price?

The difference reflects structuring, distribution and hedging costs plus issuer profit, reducing initial economic value for investors.

Are the notes listed on an exchange?

No. They will not be listed; any resale must occur through Morgan Stanley’s secondary market, which may be limited.

What credit risk do investors bear?

Payments depend on Morgan Stanley’s ability to pay. A downgrade or default could impair note value and payouts.
Flora Growth Corp

NASDAQ:FLGC

FLGC Rankings

FLGC Latest News

FLGC Stock Data

15.12M
19.67M
35.25%
8.36%
3.18%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
United States
FORT LAUDERDALE